Publications
A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft model
A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells
Chemical biology. A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice
Comparative canine pharmacokinetics-pharmacodynamics of fospropofol disodium injection, propofol emulsion, and cyclodextrin-enabled propofol solution following bolus parenteral administration
Corrigendum to: "Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers"
Development of a high-throughput screening cancer cell-based luciferase refolding assay for identifying Hsp90 inhibitors
Professor Valentino J. Stella: scientist, mentor, entrepreneur, family man, and giant in pharmaceutical chemistry
Small molecule inhibition of the CBFβ/RUNX interaction decreases ovarian cancer growth and migration through alterations in genes related to epithelial-to-mesenchymal transition
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
Sulfobutylether-β-cyclodextrin. International journal of pharmaceutics